The Team

GDMC constitutes of a vibrant and intellectual team sharing the same passion for science, innovation, and improvement.

Leadership

Michael S. Koeris

CEO and Co-Founder

View Bio

Michael S. Koeris, PhD

President and Co-Founder

With almost 14 years of experience as a serial entrepreneur, Mike has established himself as a seasoned innovator in the startup space. Mike also a professor of Bioprocessing at the Keck Graduate Institute, Claremont Colleges.

His interest in Synthetic Biology started from his graduate studies in the Collins Lab at MIT. Since then, he has co-founded and exited (though M&A and SPAC) several successful ventures, including Corvium (previously known as Sample6) and BiomX. He is also member of the Board of Directors for Addgene.

Mike is very excited about how to bring genetic medicines faster into the market by partnering up early with other startups and emerging companies and leveraging the power of synthetic biology and machine learning.

LinkedIn

Yong Keng Goh

Site Head

View Bio

Yong Keng Goh

Site Head

Yong Keng is no stranger to the Singapore pharmaceutical industry for over 35 years. He has designed over 15 facilities as well as involved in building > 6 sites around the world including USA and Taiwan for production of small molecules and large molecules. Yong Keng brings along his wealth of experience having worked before at GSK, MSD, Roche, Impax Laboratories, Intech Biopharm, Alvogen Taiwan and Amaran Biotechnology. He looks forward to bringing the magic into manufacturing genetic medicines and training the next generation of process engineers and biotechnologists.

Shao Siong Chua

Vice President of Technical Operations

View Bio

Chua Shao Siong

Vice President of Technical Operations

Shao Siong is an accomplished operations executive with over 20 years of experience in the biopharmaceutical industry. Prior to joining GDMC, he held senior leadership positions at several leading organizations, including RVAC Medicines, Novartis, Baxter (Baxalta) and GlaxoSmithKline. In these roles, Shao Siong was responsible for leading plant startups, driving operational readiness and improving operational efficiency. Shao Siong is known for his passion in people development and building high-performing teams. He looks forward to making positive impact for the patients with the engine from GDMC. He is an experienced Lean Six Sigma practitioner and has a Master of Engineering (Chemical) with Business from the National University of Singapore.

LinkedIn

Victor Gan

Director of Finance

View Bio

Victor Gan

Director of Finance

Victor’s first foray into biotech was at PRIME Biologics where he orchestrated the companies finance and implemented the correct system with the rest of the team to achieve cGMP certification by the Health Science Authority of Singapore. He has worked as a finance professional in various industries for over 18 years – chemicals, IT, tourism and investment. Victor spearheads GDMC efforts in sustainable financing and bringing affordable genetic medicines to the patients.

LinkedIn

Prashanth Basika

Director of Quality Assurance

View Bio

Prashanth Kumar Basika

Director of Quality Assurance

Quality is in the blood of Prashanth, with more than 18 years in various quality functions. Prashanth started his career as a microbiologist and moved through various functions in quality ranging from quality control, quality assurance, commissioning, qualification and regulatory compliance. He has worked at both MNCs – Roche, Genentech, Lonza, and Wyeth, as well as startups – Tessa Therapeutics and Tychan. With his experience in different sized companies, Prashanth is leading GDMC’s quality team to build the appropriate quality systems for both GDMC and our partners.

Sau Yin Chin

Director of Operations and Projects

View Bio

Sau Yin Chin, PhD

Director of Operations and Projects

Sau Yin started off her career as a scientist, having graduated from Columbia University with a PhD in Biomedical Engineering. She subsequently decided to take the dive into biotech startups due to a keen interest in seeing technologies being translated into clinic. Prior to GDMC, she was the first employee at a small molecule protein degrader startup and was the Director of Operations. At GDMC, she is responsible for ensuring operational efficiency and collaborative project management for partners.

Brian Liau

Associate Director of Analytics Development

View Bio

Brian Liau, PhD

Associate Director of Analytics Development

Brian has held diverse roles in both academia and industry over the past 15 years. After receiving his PhD in Biomedical Engineering from Duke University, Brian assumed the role of lead investigator in functional glycobiology at the Bioprocessing Technology Institute (A*STAR) where his team developed new analytical platforms for profiling anti-cancer immune responses. He was most recently a Biopharma lead scientist at Agilent Technologies, where he created an R&D programme to address emerging quality and safety needs in adeno-associated viral vectors, mRNA vaccines and lipid nanoparticles with advances in LC-MS and spectroscopy. Brian leads GDMC’s efforts to gain a deeper understanding of genetic medicines and their associated manufacturing processes through advanced analytical methodologies.

Ming-Chien Li

Associate Director of Quality Control

View Bio

Ming-Chien Li, PhD

Associate Director of Quality Control

Ming-Chien started her career in analytics on fluorescent molecules in a separation science lab at Texas A&M. She started her career in pharma from analytics before moving into quality control. Her deep experience in pharmaceutical industry for over 8 years has seen her across various roles, giving her strong perspectives on the different needs in producing therapeutics. Ming-Chien is keen to bring quality genetic medicines to patients.

LinkedIn

Han Teng Wong

Associate Director of Research and Development

View Bio

Han Teng Wong, PhD

Associate Director of Research and Development

Han Teng received his PhD in Microbiology from the University of California, Berkeley under Prof Danielle Tullman-Ercek. At the Tullman-Ercek lab, he worked on engineering the Type III secretion system for protein production in bacteria, using both protein engineering and strain engineering approaches. Prior to GDMC, he was the lead PI for a multi-institute research project at the multidisciplinary Molecular Engineering Lab (A*STAR) on engineering sweet proteins for use in the food industry including the use of machine learning-guided methods in protein engineering. Han Teng spearheads the R&D department to apply both synthetic biology and machine learning to design for manufacturability as well as develop innovation approaches to manufacturing cell, gene and nucleic acids therapies.

CULTURE & VALUES

What’s in GDMC’s DNA

Diversity

We are dedicated to creating a workplace that is inclusive for all, where individuals feel valued, respected and empowered.

Agility

We encourage innovation, entrepreneurship and continuously learning; adapting to changes and seizing new opportunities.

Integrity

We hold ourselves and each other accountable, honest, transparent and responsible for manufacturing high quality, life-saving medicines.

Collaboration

We foster a culture that values teamwork towards building strong partnerships with our customers, suppliers and stakeholders to drive success.

Excellence

We are committed to being the best-in-class for Quality, Safety, Science, Technology & Delivery, and will celebrate outstanding achievements.

Partner with Us.

With your science and our quality-driven expertise, magical things can happen. Let’s start the conversation!